Fulvia Ceccarelli

Pubblicazioni

Titolo Pubblicato in Anno
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab. a case report RHEUMATOLOGY 2021
Response to: `correspondence on `{SARS}-{CoV}-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists'' by smerilli et al ANNALS OF THE RHEUMATIC DISEASES 2021
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view ANNALS OF THE RHEUMATIC DISEASES 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients JOURNAL OF AUTOIMMUNITY 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica SCIENTIFIC REPORTS 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells EBIOMEDICINE 2020
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion CLINICAL AND TRANSLATIONAL IMMUNOLOGY 2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells ANNALS OF ONCOLOGY 2020
Joint involvement influences quality of life in systemic lupus erythematosus patients LUPUS 2020
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis RHEUMATOLOGY 2020
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2020
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES 2020
FRI0159 EROSIVE ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: APPLICATION OF CLUSTER ANALYSIS Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES 2020
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients LUPUS 2020
Treatment with gonadotropin releasing hormone agonists in systemic lupus erythematosus patients receiving cyclophosphamide: A long-term follow-up study ISRAEL MEDICAL ASSOCIATION JOURNAL 2020
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study ISRAEL MEDICAL ASSOCIATION JOURNAL 2020
The Impact of Caffeine Intake on Patients with Systemic Lupus Erythematosus: Protect Yourself, Drink More Coffee! MEDITERRANEAN JOURNAL OF RHEUMATOLOGY 2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic ANNALS OF THE RHEUMATIC DISEASES 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting ARTHRITIS & RHEUMATOLOGY 2020
Remission in systemic lupus erythematosus: Testing different definitions in a large multicentre cohort ANNALS OF THE RHEUMATIC DISEASES 2020

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma